Arlington, MA, United States of America

Sachin Maniar



 

Average Co-Inventor Count = 15.0

ph-index = 2

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 2017-2020

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):

Title: The Innovative Contributions of Sachin Maniar

Introduction

Sachin Maniar is a notable inventor based in Arlington, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit protein kinases. With a total of 3 patents to his name, his work has the potential to impact various therapeutic areas.

Latest Patents

Sachin's latest patents include innovative compounds such as substituted pyrido[2,3-d]pyrimidines. These compounds are designed as inhibitors of protein kinases, which play a crucial role in cell signaling and regulation. The first patent provides substituted pyrido[2,3-d]pyrimidine compounds that are useful as inhibitors of protein kinases, along with pharmaceutically acceptable compositions and methods of use. The second patent also focuses on similar compounds of formula I-h, emphasizing their utility in inhibiting protein kinases.

Career Highlights

Throughout his career, Sachin has worked with prominent companies in the pharmaceutical industry, including Celgene and Sanofi. His experience in these organizations has allowed him to collaborate with leading experts and contribute to groundbreaking research.

Collaborations

Some of Sachin's notable coworkers include Laura Akullian D'Agostino and Robert Tjin Tham Sjin. Their collaborative efforts have further advanced the research and development of innovative pharmaceutical solutions.

Conclusion

Sachin Maniar's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments and therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…